Lactic acid–induced FBXL6 promotes NLRP3 inflammasome activation through activation of JNK signaling pathway in gastric cancer

F-box and leucine-rich repeat protein 6 (FBXL6), an essential component of the ubiquitin–proteasome system, regulates diverse cellular processes; however, its specific role in gastric cancer remains uncertain. This study aimed to elucidate the molecular mechanisms by which FBXL6 regulates gastric cancer cell growth, with a particular focus on its involvement in NLRP3 inflammasome activation. The potential involvement of FBXL6 in gastric cancer-related molecular pathways was first investigated using gene set enrichment analysis. Functional validation was performed in two gastric cancer cell lines (MKN45 and MKN28), a nude mouse xenograft model, and a gastric cancer tissue microarray by assessing cell proliferation, cell cycle progression, and the interactions of FBXL6 with dual-specificity phosphatase 6 (DUSP6), the c-Jun N-terminal kinase (JNK) pathway, and NLRP3 inflammasome activation. FBXL6 silencing suppressed cell growth, NLRP3 inflammasome activation, and JNK phosphorylation in MKN45 cells. In MKN28 cells, FBXL6 overexpression induced activation of NLRP3 inflammasome and increased intracellular LDH activity and lactic acid release, which were reversed by the JNK inhibitor SP600125, and its growth-promoting effect was counteracted by the NLRP3 inflammasome inhibitor MCC950. Mechanistically, FBXL6 downregulated DUSP6 expression by promoting its ubiquitination. Moreover, lactic acid-mediated H3K18 lactylation promoted FBXL6 transcription, thereby activating JNK signaling. The role of the FBXL6–DUSP6–JNK axis in tumor development was further validated in a nude mouse xenograft model. Collectively, our findings identify FBXL6 as a potential oncogene factor in gastric cancer via ubiquitination of DUSP6 to promote JNK signaling and NLRP3 inflammasome activation, highlighting the potential positive feedback loop of lactate–FBXL6–DUSP6–JNK as a promising therapeutic strategy for gastric cancer.

Authors

Institutions

Publication Details

Journal
Cell Biology and Toxicology
Published
2026-11-21
DOI
https://doi.org/10.1007/s10565-026-10369-8
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lactic acid–induced FBXL6 promotes NLRP3 inflammasome activation through activation of JNK signaling pathway in gastric cancer

朱侃恺, Hang Yu, Chunhui Shou, Xiaofeng Chu et al.
Cell Biology and Toxicology
Inflammasome and immune disorders
article

Lactic acid–induced FBXL6 promotes NLRP3 inflammasome activation through activation of JNK signaling pathway in gastric cancer

朱侃恺, Hang Yu, Chunhui Shou, Xiaofeng Chu, Xiaosun Liu, Hailong Jin, Yang Dong, Xiaokun Liu
article en

Abstract

F-box and leucine-rich repeat protein 6 (FBXL6), an essential component of the ubiquitin–proteasome system, regulates diverse cellular processes; however, its specific role in gastric cancer remains uncertain. This study aimed to elucidate the molecular mechanisms by which FBXL6 regulates gastric cancer cell growth, with a particular focus on its involvement in NLRP3 inflammasome activation. The potential involvement of FBXL6 in gastric cancer-related molecular pathways was first investigated using gene set enrichment analysis. Functional validation was performed in two gastric cancer cell lines (MKN45 and MKN28), a nude mouse xenograft model, and a gastric cancer tissue microarray by assessing cell proliferation, cell cycle progression, and the interactions of FBXL6 with dual-specificity phosphatase 6 (DUSP6), the c-Jun N-terminal kinase (JNK) pathway, and NLRP3 inflammasome activation. FBXL6 silencing suppressed cell growth, NLRP3 inflammasome activation, and JNK phosphorylation in MKN45 cells. In MKN28 cells, FBXL6 overexpression induced activation of NLRP3 inflammasome and increased intracellular LDH activity and lactic acid release, which were reversed by the JNK inhibitor SP600125, and its growth-promoting effect was counteracted by the NLRP3 inflammasome inhibitor MCC950. Mechanistically, FBXL6 downregulated DUSP6 expression by promoting its ubiquitination. Moreover, lactic acid-mediated H3K18 lactylation promoted FBXL6 transcription, thereby activating JNK signaling. The role of the FBXL6–DUSP6–JNK axis in tumor development was further validated in a nude mouse xenograft model. Collectively, our findings identify FBXL6 as a potential oncogene factor in gastric cancer via ubiquitination of DUSP6 to promote JNK signaling and NLRP3 inflammasome activation, highlighting the potential positive feedback loop of lactate–FBXL6–DUSP6–JNK as a promising therapeutic strategy for gastric cancer.

Cell Biology and Toxicology
First People's Hospital of Yuhang District (CN), Hangzhou Medical College (CN), First Affiliated Hospital Zhejiang University (CN)
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon